InterCure Ltd. (INCR) Insider Trading Activity

NASDAQ$0.82
Market Cap
$44.85M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
618 of 883
Rank in Industry
32 of 48

INCR Insider Trading Activity

INCR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About InterCure Ltd.

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Insider Activity of InterCure Ltd.

Over the last 12 months, insiders at InterCure Ltd. have bought $0 and sold $0 worth of InterCure Ltd. stock.

On average, over the past 5 years, insiders at InterCure Ltd. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $43,187 was made by Burgstahler David F () on 2016‑09‑19.

List of Insider Buy and Sell Transactions, InterCure Ltd.

2017-09-18SaleRush Gregory SChief Financial Officer
9,703
0.8684%
$54.48
$528,600
-19.43%
2017-09-18SaleGaenzle Christopher LCAO, GC & Sec
4,682
0.4196%
$54.55
$255,427
-19.43%
2017-09-01SaleRush Gregory SChief Financial Officer
88,739
8.5995%
$58.99
$5.23M
-11.52%
2017-09-01SaleGaenzle Christopher LCAO, GC & Sec
42,601
4.1062%
$58.67
$2.5M
-11.52%
2017-08-30SaleRush Gregory SChief Financial Officer
41,420
3.9647%
$58.26
$2.41M
-10.37%
2017-07-03SaleGaenzle Christopher LCAO, GC & Sec
956
0.092%
$58.55
$55,974
+18095.49%
2017-06-30SaleGaenzle Christopher LCAO, GC & Sec
5,917
0.5666%
$58.28
$344,872
+18095.49%
2017-04-03SaleGaenzle Christopher LCAO, GC & Sec
4,733
0.3554%
$45.70
$216,298
+18095.49%
2017-01-20SaleRush Gregory SExecutive VP and CFO
1,573
0.1305%
$50.50
$79,437
+18095.49%
2017-01-20SaleGaenzle Christopher LCAO, GC & Sec
1,186
0.0976%
$50.09
$59,406
+18095.49%
2017-01-19SaleRush Gregory SExecutive VP and CFO
1,334
0.111%
$50.65
$67,567
+18095.49%
2017-01-03SaleRush Gregory SExecutive VP and CFO
41,420
3.5319%
$51.90
$2.15M
+18112.20%
2017-01-03SaleGaenzle Christopher LCAO, GC & Sec
15,383
1.3117%
$51.90
$798,420
+18112.20%
2016-09-30SaleRush Gregory SExecutive VP and CFO
35,503
2.6071%
$44.70
$1.59M
+18438.01%
2016-09-27SaleMacdonald D. JamieChief Executive Officer
53,970
3.9283%
$44.30
$2.39M
+18446.37%
2016-09-26SaleBreckon Robert Wdirector
12,197
0.8849%
$44.16
$538,625
+18446.37%
2016-09-19PurchaseBurgstahler David F
1,000
0.071%
$43.19
$43,187
+18529.91%
2016-09-14SaleGaenzle Christopher LCAO, GC & Sec
4,734
0.3355%
$43.14
$204,234
+18563.32%
2016-08-04Sale
ONTARIO TEACHERS PENSION PLAN BOARD
2.45M
–
$42.06
$102.86M
+18446.37%
2016-08-02SaleMacdonald D. JamieChief Executive Officer
31,279
2.2097%
$43.00
$1.34M
+18563.32%
Total: 66

INCR Institutional Investors: Active Positions

Increased Positions5+20%67,951+3.22%
Decreased Positions8-32%1M-69.02%
New Positions0New0New
Sold Out Positions4Sold Out1MSold Out
Total Postitions22-12%721,268-65.79%

INCR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Goldman Sachs Group Inc$1,301.002.3%1.26M+1MNew2025-09-30
Jane Street Group, Llc$221.000.39%214,253+214,253New2025-09-30
Healthcare Of Ontario Pension Plan Trust Fund$219.000.39%212,50000%2025-09-30
Advisorshares Investments Llc$112.000.2%108,88400%2025-09-30
Moore Capital Management, Lp$100.000.18%97,27300%2025-09-30
Renaissance Technologies Llc$66.000.12%63,700+14,800+30.27%2025-09-30
Stonex Group Inc.$51.000.09%49,541+49,541New2025-09-30
Blackrock, Inc.$25.000.04%24,16200%2025-09-30
Geode Capital Management, Llc$23.000.04%22,53900%2025-09-30
Citadel Advisors Llc$13.000.02%12,775-28,293-68.89%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.